| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | CI | | CoAprovel 150/12.5 - T | 28 Tablet(s) | 10.19 | 27.45 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G |  |
| | | IP | CI | | CoAprovel 150/12.5 - T | 98 Tablet(s) | 32.89 | 52.00 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | CoAprovel 300/12.5 - T | 28 Tablet(s) | 13.76 | 31.30 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | CoAprovel 300/12.5 - T | 98 Tablet(s) | 47.53 | 67.85 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | CoAprovel 300/25 - T | 28 Tablet(s) | 13.93 | 31.50 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | CoAprovel 300/25 - T | 98 Tablet(s) | 48.10 | 66.55 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
150/12,5 mg | 28 Tablet(s) | 9.29 | 26.50 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
150/12,5 mg | 98 Tablet(s) | 29.98 | 49.00 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
300/12,5 mg | 28 Tablet(s) | 12.55 | 30.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
300/12,5 mg | 98 Tablet(s) | 43.33 | 63.55 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
300/25 mg | 28 Tablet(s) | 12.70 | 30.25 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
300/25 mg | 98 Tablet(s) | 43.84 | 64.10 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
150/12.5 mg | 28 Tablet(s) | 9.29 | 26.50 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
150/12.5 mg | 98 Tablet(s) | 29.98 | 49.00 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/12.5 mg | 28 Tablet(s) | 12.55 | 30.05 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/12.5 mg | 98 Tablet(s) | 43.33 | 63.55 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
150/12.5 mg | 28 Tablet(s) | 9.29 | 26.50 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
150/12.5 mg | 98 Tablet(s) | 29.99 | 49.05 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
300/12.5 mg | 28 Tablet(s) | 12.55 | 30.05 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
300/12.5 mg | 98 Tablet(s) | 43.33 | 63.55 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
300/25 mg | 28 Tablet(s) | 12.70 | 30.25 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
300/25 mg | 98 Tablet(s) | 43.85 | 64.10 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
150mg/12.5mg | 28 Tablet(s) | 9.25 | 26.50 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
150mg/12.5mg | 98 Tablet(s) | 29.84 | 48.90 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/12.5mg | 28 Tablet(s) | 12.49 | 30.00 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/12.5mg | 98 Tablet(s) | 43.11 | 63.30 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/25mg | 28 Tablet(s) | 12.64 | 30.15 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/25mg | 98 Tablet(s) | 43.63 | 63.90 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/25 mg | 28 Tablet(s) | 12.70 | 30.25 | 10 % | | Filmtablette: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/25 mg | 98 Tablet(s) | 43.84 | 64.10 | 10 % | | Filmtablette: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
|
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 8/12.5 mg | 28 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 8/12.5 mg | 98 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 16/12.5 mg | 28 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 16/12.5 mg | 98 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 32/12.5 mg | 28 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 32/12.5 mg | 98 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 32/25 mg | 28 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | CM | CANDESARTAN PLUS
CHEPLAPHARM 32/25 mg | 98 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | | Atacand plus 8/12.5 mg | 28 Tablet(s) | 8.29 | 18.20 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | | G | |
| | | IP | CI | | Atacand plus 8/12.5 mg | 98 Tablet(s) | 27.09 | 45.75 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Atacand plus 16/12.5 mg ‐ I | 28 Tablet(s) | 10.27 | 27.55 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Atacand plus 16/12.5 mg ‐ I | 98 Tablet(s) | 35.85 | 55.20 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Atacand plus 32/12.5 mg | 28 Tablet(s) | 11.35 | 28.70 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Atacand plus 32/12.5 mg | 98 Tablet(s) | 37.38 | 56.90 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Atacand plus 32/25 mg | 28 Tablet(s) | 11.35 | 28.70 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | | G | |
| | | IP | CI | | Atacand plus 32/25 mg | 98 Tablet(s) | 37.38 | 56.90 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Blopress Plus 8/12.5 mg | 28 Tablet(s) | 8.29 | 18.20 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | | G | |
| | | IP | CI | | Blopress Plus 8/12.5 mg | 98 Tablet(s) | 27.09 | 45.75 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Blopress Plus 16/12.5 mg | 28 Tablet(s) | 10.27 | 27.55 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | | G | |
| | | IP | CI | | Blopress Plus 16/12.5 mg | 98 Tablet(s) | 35.85 | 55.20 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Blopress Plus 32/12.5 mg | 28 Tablet(s) | 11.14 | 28.50 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | ● B / SL / SO | FB | | G | |
| | | IP | CI | | Blopress Plus 32/12.5 mg | 98 Tablet(s) | 37.38 | 56.90 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Blopress Plus 32/25 mg | 28 Tablet(s) | 11.75 | 29.10 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Blopress Plus 32/25 mg | 98 Tablet(s) | 37.38 | 56.90 | 10 % | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Pemzek PLUS 8/12.5 mg | 28 Tablet(s) | 8.29 | 18.20 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Pemzek PLUS 8/12.5 mg | 98 Tablet(s) | 27.09 | 45.75 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Pemzek PLUS 16/12.5 mg | 28 Tablet(s) | 10.26 | 27.55 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Pemzek PLUS 16/12.5 mg | 98 Tablet(s) | 35.85 | 55.20 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Pemzek PLUS 32/12.5 mg | 28 Tablet(s) | 14.94 | 32.40 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Pemzek PLUS 32/12.5 mg | 98 Tablet(s) | 37.38 | 56.90 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Pemzek PLUS 32/25 mg | 28 Tablet(s) | 14.94 | 32.40 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Pemzek PLUS 32/25 mg | 98 Tablet(s) | 37.38 | 56.90 | 10 % | | Tablets: 2 Active Agents | AstraZeneca AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Candesartan HCT Zentiva
8/12.5mg | 30 | 8.23 | 18.15 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Candesartan HCT Zentiva
8/12.5mg | 100 | 25.59 | 44.20 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Candesartan HCT Zentiva
16/12.5mg | 30 | 10.19 | 27.45 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Candesartan HCT Zentiva
16/12.5mg | 100 | 33.87 | 53.20 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Candesartan HCT Zentiva
32/12.5mg | 28 | 11.01 | 28.35 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Candesartan HCT Zentiva
32/12.5mg | 98 | 37.38 | 56.90 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Candesartan HCT Zentiva
32/25 mg | 28 | 11.01 | 28.35 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Candesartan HCT Zentiva
32/25 mg | 98 | 37.38 | 56.90 | 10 % | | Tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Cansartan-Mepha plus
8/12.5 | 28 Tablet(s) | 7.27 | 17.15 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Cansartan-Mepha plus
8/12.5 | 98 Tablet(s) | 23.77 | 42.35 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Cansartan-Mepha plus
16/12.5 | 28 Tablet(s) | 9.01 | 26.25 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Cansartan-Mepha plus
16/12.5 | 98 Tablet(s) | 31.45 | 50.70 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Cansartan-Mepha plus
32/12.5 | 28 Tablet(s) | 9.84 | 27.15 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Cansartan-Mepha plus
32/12.5 | 98 Tablet(s) | 32.37 | 51.75 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Cansartan-Mepha plus
32/25 | 28 Tablet(s) | 9.84 | 27.15 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Cansartan-Mepha plus
32/25 | 98 Tablet(s) | 32.37 | 51.75 | 10 % | | Tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Sandoz
8/12.5 mg | 28 Tablet(s) | 7.68 | 17.60 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Sandoz
8/12.5 mg | 98 Tablet(s) | 25.08 | 43.70 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Sandoz
16/12.5 mg | 28 Tablet(s) | 9.51 | 26.75 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Sandoz
16/12.5 mg | 98 Tablet(s) | 33.19 | 52.50 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Sandoz
32/12.5 mg | 28 Tablet(s) | 10.57 | 27.90 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Sandoz
32/12.5 mg | 98 Tablet(s) | 34.79 | 54.25 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Sandoz
32/25 mg | 28 Tablet(s) | 10.57 | 27.90 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Sandoz
32/25 mg | 98 Tablet(s) | 34.79 | 54.25 | 10 % | | Tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Spirig HC
8/12,5mg | 28 | 7.65 | 17.55 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Spirig HC
8/12,5mg | 98 | 25.05 | 43.65 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Spirig HC
16/12,5mg | 28 | 9.45 | 26.70 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Spirig HC
16/12,5mg | 98 | 33.15 | 52.45 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Spirig HC
32/12,5mg | 28 | 10.57 | 27.90 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Spirig HC
32/12,5mg | 98 | 34.79 | 54.25 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Spirig HC
32/25mg | 28 | 10.57 | 27.90 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Candesartan Spirig HC
32/25mg | 98 | 34.79 | 54.25 | 10 % | | Tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atacand plus 8/12.5 mg | 30 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | | Atacand plus 16/12.5 mg | 30 | PR | PR | k.A. | | Tablets: 2 Active Agents | Cheplapharm Schweiz
GmbH | B | FB | | G | |
| | | IP | CI | | Pemzek PLUS 8/12.5 mg | 30 | PR | PR | k.A. | | Tablets: 2 Active Agents | AstraZeneca AG | B | FB | | G | |
| | | IP | CI | | Pemzek PLUS 16/12.5 mg | 30 | PR | PR | k.A. | | Tablets: 2 Active Agents | AstraZeneca AG | B | FB | | G | |
|
| | | IP | CI | PP | Edarbyclor 40 mg/12.5 mg | 28 Tablet(s) | 23.28 | 41.75 | 10 % | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B / SL | FB | | G | |
| | | IP | CI | PP | Edarbyclor 40 mg/12.5 mg | 98 Tablet(s) | 76.36 | 99.45 | 10 % | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B / SL | FB | | G | |
| | | IP | CI | PP | Edarbyclor 40 mg/25 mg | 28 Tablet(s) | 24.41 | 42.95 | 10 % | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B / SL | FB | | G | |
| | | IP | CI | PP | Edarbyclor 40 mg/25 mg | 98 Tablet(s) | 80.06 | 103.50 | 10 % | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B / SL | FB | | G | |
| | | IP | CI | PP | Edarbyclor 40 mg/12.5 mg | 56 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B | FB | | G | |
| | | IP | CI | PP | Edarbyclor 40 mg/25 mg | 56 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Takeda Pharma AG | B | FB | | G | |
